At Allegheny General Hospital in Pittsburgh, PA, USA, David S. Parda, MD, and his team from the Department of Radiation Oncology are combining Siemens ARTISTE™ integrated imaging and radiation therapy solution with Brainlab's stereotactic radiotherapy and surgery technology. The aim is to increase cure rates, quality of life and, ultimately, life span for difficult-to-treat patients. Parda finds this combination particularly useful for treating patients with brain, lung, spine, and liver tumors that have to undergo second or even third-line treatment for their primary tumors or patients who suffer from metastatic disease.

With its capabilities for intensity-modulated and image-guided radiation therapy as well as both megavoltage and kilovoltage¹ cone beam in-line imaging capabilities, the ARTISTE solution is ideally suited to achieve great dose and targeting precision. Parda calls it "the most complete and comprehensive solution for radiation therapy." To help ensure maximum dose to target volume while minimizing dose to surrounding tissue, ARTISTE solution's In-Line™ imaging enables physicians to verify the tumor's exact position immediately prior to treatment, and adapt to any anatomical changes immediately before – or in some cases during – treatment. The system also offers the ability to incorporate the dose used for pretreatment imaging into the treatment plan so that clinicians can accurately monitor the dose delivered to the patient.